Jade Biosciences, Inc. (JBIO)

Jade Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	-	23.49	22.4	54.2
Short-Term Investments	247.72	-	98.95	106.82	113.18
Cash & Short-Term Investments	247.72	-	122.44	129.22	167.38
Cash Growth	-	-	-5.25%	-22.80%	3560.07%
Other Current Assets	12.66	0.27	1.79	2.28	6.96
Total Current Assets	348.82	69.65	124.23	131.5	174.33
Net Property, Plant & Equipment	0.9	-	0.9	1.25	0.73
Other Long-Term Assets	0.07	3.15	2.28	2.56	0.3
Total Assets	349.78	72.8	127.42	135.3	175.36
Accounts Payable	2.15	1.29	2.4	2.58	1.21
Accrued Expenses	14.39	9.63	14.82	4.82	1.15
Current Portion of Leases	-	-	0.42	0.39	0.19
Other Current Liabilities	-	1.08	-	-	-
Total Current Liabilities	16.54	12	17.64	7.78	2.55
Long-Term Debt	-	107.6	-	-	-
Long-Term Leases	0.72	-	0.26	0.71	0.38
Other Long-Term Liabilities	-	-	0.07	0.07	0.01
Total Long-Term Liabilities	0.72	107.6	0.33	0.78	0.4
Total Liabilities	17.26	119.6	17.96	8.56	2.95
Preferred Stock	0	-	-	-	-
Common Stock	-	-	0	0	0
Additional Paid-in Capital	-	-	272.64	215.11	208.87
Accumulated Other Comprehensive Income	0.13	-	0.24	-0.47	-0.06
Retained Earnings	-	-	-163.42	-87.9	-36.39
Total Common Shareholders' Equity	0.13	-	109.46	126.74	172.42
Minority Interest	-	0	-	-	-
Shareholders' Equity	0.13	0	109.46	126.74	172.42
Total Liabilities & Equity	17.39	119.6	127.42	135.3	175.36
Total Debt	0.72	107.6	0.68	1.09	0.57
Net Cash (Debt)	247	-107.6	121.76	128.13	166.8
Net Cash Growth	-	-	-4.97%	-23.18%	3547.52%
Net Cash Per Share	7.88	-131.76	161.85	183.25	474.88
Book Value	0.13	0	109.46	126.74	172.42
Book Value Per Share	0.00	-	145.49	181.27	490.87
Tangible Book Value	0.13	0	109.46	126.74	172.42
Tangible Book Value Per Share	0.00	-	145.49	181.27	490.87

Updated Mar 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q